Global Canine Atopic Dermatitis Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Canine Atopic Dermatitis Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global canine atopic dermatitis market has been segmented on the basis of product, mode of administration, distribution channel, as well as regions and countries.
Atopic dermatitis is a pruritic (itchy) skin disease, common among cats and dogs. This condition is the result of an allergic reaction that occurs when an animal inhales airborne substances (dust, pollen) or ingests a substance that they are sensitive to. This allergic reaction causes the animal to lick, rub, bite, or scratch the affected surface area.
The surging number of veterinary practitioners is a primary factor that is expected to fuel revenue growth of the global canine atopic dermatitis market in the years to come. Additionally, the rising number of veterinary clinics and hospitals are also expected to contribute to future revenue growth.
Other factors that are anticipated to play a crucial role in the revenue growth of this global market are a strong drug pipeline, new product launches, as well as increasing investments being made by key industry players. Furthermore, the stringent enforcement of regulations by governing bodies such as the Food and Drug Administration (FDA) to lower the off label usage of human drugs on animals is slated to boost future market growth. The increasing concern among pet owners, as well as the demand for pet insurance are also expected to positively influence this market.
Segmentation of the global canine atopic dermatitis market is as follows:
In terms of product, the glucocorticoids segment accounted for the majority revenue share of the global canine atopic dermatitis market in 2019, owing to its cheaper cost and increased usage. The Monoclonal Antibodies (MAbs) segment is expected to index considerable revenue growth in the foreseeable future.
On the basis of mode of administration, the oral segment accounted for the highest number of revenue shares of the global canine atopic dermatitis market. Although, the injectable segment is expected to index substantial revenue growth due to its potency and efficacy.
With respect to distribution channel, the retail segment accounted for the highest revenue shares of this global market in 2019, due to increased product availability. The increasing popularity of e-commerce channels due to greater convenience levels is further contributing to future revenue sales of this global market.
Regional Segmentation and Analysis:
North America accounted for the majority revenue share of the global canine atopic dermatitis market in 2019, and is expected to continue to do so over the next 10 years. This can be attributed to the increasing incidence of atopic dermatitis, new product launches, as well as the rising number of pet owners in this region.
Segmentation of the Global Canine Atopic Dermatitis Market:
Segmentation by Product:
Segmentation by Mode of Administration:
Segmentation by Distribution Channel:
- Veterinary Hospitals/Clinics
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Toray Industries
- Kindred Biosciences
- AB Science
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!